We are live on ! Find out more
CALC icon

CalciMedica
CALC

11 hedge funds and large institutions have $1.49M invested in CalciMedica in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

0.27% less ownership

Funds ownership: 2.09% → 1.82% (-0.27%)

5% less capital invested

Capital invested by funds: $1.56M → $1.49M (-$76.8K)

8% less funds holding

Funds holding: 12 → 11 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
2
Closed
1
Calls
$269K
Puts
–
Net Calls
+$269K
Net Calls Change
+$26K

Top Buyers

Rank Fund Capital Flow
1
BCM
BML Capital Management
Indiana
+$164K
2
MPM
Meritage Portfolio Management
Kansas
+$104K
3
TRCT
Tower Research Capital (TRC)
New York
+$3.54K
4
Bank of America
Bank of America
North Carolina
+$1.37K

Top Sellers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$432K
2
Morgan Stanley
Morgan Stanley
New York
-$2.02K
3
UBS Group
UBS Group
Switzerland
-$1.22K

CALC Hedge Fund Activity: Q4 2023 in Review

11 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q4 2023, worth a combined $1.49M — down 4.9% from $1.56M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CALC and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 4 added.

The largest buyer was BML Capital Management, adding an estimated $164K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $432K sold.

  • 11 institutional investors held CalciMedica (CALC) as of Q4 2023, down from 12 in Q3 2023.
  • Funds reported $1.49M of CalciMedica stock for Q4 2023, down 4.9% quarter-over-quarter.
  • 0 funds opened new CalciMedica positions in Q4 2023 and 1 closed out, a net change of -1 holder.
  • The largest CalciMedica buyer in Q4 2023 was BML Capital Management, an estimated $164K added.
  • The largest CalciMedica seller in Q4 2023 was Hudson Bay Capital Management, an estimated $432K sold.

Based on aggregated 13F filings for Q4 2023.